Showing results (531-540 of 545) with videos related to
Sort By:
Pageof 55
Journal for Immunotherapy of Cancer|June 18, 2022
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumorsDionysis Papadatos-Pastos, Wei Yuan, Abhijit Pal, et al.Cancer Discovery|September 22, 2020
Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid CancersJavier Pascual, Joline S J Lim, Iain R Macpherson, et al.Nature|December 2, 2005
Rain, winds and haze during the Huygens probe's descent to Titan's surfaceM G Tomasko, B Archinal, T Becker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2026
Phase I trial of Ipatasertib plus Atezolizumab enhances PI3K/AKT pathway immune responses in solid tumors and refractory glioblastomaCrescens Tiu, Wing Yau, Diogo Silva, et al.Nature|October 16, 2023
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistanceChristina Guo, Adam Sharp, Bora Gurel, et al.Genome Announcements|June 20, 2015
Genome Sequences of Mycobacteriophages AlanGrant, Baee, Corofin, OrangeOswald, and Vincenzo, New Members of Cluster BWelkin H Pope, Maria E Carbonara, Hanna M Cioffi, et al.Physical Review Letters|December 12, 2001
Precision measurement of the spin-dependent asymmetry in the threshold region of 3He(e, e')F Xiong, D Dutta, W Xu, et al.Physical Review Letters|February 3, 2004
Q2 evolution of the neutron spin structure moments using a 3He targetM Amarian, L Auerbach, T Averett, et al.Physical Review Letters|September 27, 2000
Transverse asymmetry AT' from the quasielastic 3He(e,e') process and the neutron magnetic form factorW Xu, D Dutta, F Xiong, et al.Physical Review Letters|December 18, 2002
Q2 evolution of the generalized Gerasimov-Drell-Hearn integral for the neutron using a 3He targetM Amarian, L Auerbach, T Averett, et al.Pageof 55